Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.33
06.03.23
-
06.03.24
-96.62%
07.03.24

Alliance Global Partners 
06.03.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€165.86
06.03.23
€173.60
06.03.24
26.85%
07.03.24

Needham & Company LLC 
06.03.23 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.50
06.03.23
€60.06
06.03.24
-10.61%
07.03.24

Morgan Stanley 
06.03.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.83
06.03.23
€15.01
06.03.24
-52.04%
07.03.24

Needham & Company LLC 
06.03.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€136.50
06.03.23
€191.43
06.03.24
-20.88%
07.03.24

HC Wainwright 
06.03.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.83
06.03.23
€20.64
06.03.24
-52.04%
07.03.24

HC Wainwright 
06.03.23 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.29
06.03.23
-
06.03.24
-13.18%
17.03.23

Risky Investment
thomasw 
06.03.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.44
06.03.23
-
06.03.24
-57.46%
17.03.23

Could be worthwhile Investment >10% per year
thomasw 
06.03.23 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.55
06.03.23
€3.00
06.03.24
-38.59%
16.04.23

Some uniques
Significant cyclical dependencies
Little known brand
Higher risks for its business
kostojunior 
06.03.23 100%
sell
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€85.00
06.03.23
€66.00
06.03.24
91.76%
07.03.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Innovative
kostojunior 
06.03.23 30%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€7.14
05.03.23
-
05.03.24
-22.15%
18.03.23

Probably not worthwhile Investment
Very low/no dividend yield expected
fenjal 
05.03.23 50%
sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.77
05.03.23
-
05.03.24
120.34%
06.03.24

StockNews.com 
05.03.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.62
05.03.23
-
05.03.24
-72.14%
06.03.24

StockNews.com 
05.03.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
05.03.23
-
05.03.24
-
06.03.24

StockNews.com 
05.03.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€8.05
05.03.23
-
05.03.24
-33.54%
06.03.24

StockNews.com 
05.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
05.03.23
-
05.03.24
-35.75%
06.03.24

StockNews.com 
05.03.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.95
05.03.23
-
05.03.24
-55.37%
06.03.24

StockNews.com 
05.03.23 50%
sell
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.04
04.03.23
-
04.03.24
669.74%
05.03.24

StockNews.com 
04.03.23 50%
buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€5.90
04.03.23
-
04.03.24
-34.24%
05.03.24

StockNews.com 
04.03.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
04.03.23
-
04.03.24
-
05.03.24

StockNews.com 
04.03.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€137.36
03.03.23
€199.47
03.03.24
-19.63%
04.03.24

The Goldman Sachs Group, Inc. 
03.03.23 50%
sell
Innoviva Inc.

Start price
Target price
Perf. (%)
€10.40
03.03.23
€9.43
03.03.24
32.69%
04.03.24

Morgan Stanley 
03.03.23 50%
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€10.40
03.03.23
€21.21
03.03.24
32.69%
04.03.24

EF Hutton Acquisition Co. I 
03.03.23 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€15.98
03.03.23
€22.62
03.03.24
26.83%
04.03.24

EF Hutton Acquisition Co. I 
03.03.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%